Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Resectable Osteosarcoma

NCT05726383 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.

NCT NCT05726383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05726383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Resectable Osteosarcoma
Lead sponsor
Hackensack Meridian Health
Phase
Phase 2
Overall status
Recruiting
Start date
May 14, 2024
Completion date
May 11, 2027
Enrollment
32 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteogenic sarcoma recurrent